Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
Jul 22, 2026, 9:30 AM EST
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $342.93 thousand as of July 23, 2026. Its market cap has decreased by -47.76% in one year.
Market Cap
342.93K
Enterprise Value
1.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 342.93K, a decrease of -99.80%. That is a compound annual growth rate of -40.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 342.93K | -35.13% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sorrento Therapeutics | 543.71K |
| Halberd | 523.11K |
| CERo Therapeutics Holdings | 520.44K |
| Protagenic Therapeutics | 471.20K |
| THC Farmaceuticals | 435.16K |
| Helix BioMedix | 402.23K |
| IO Biotech | 395.72K |
| Actavia Life Sciences | 385.91K |